Stock comparison
argenx SE
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ARGX
argenx SE
Market cap
$49.91B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ARGX | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 60C | 69B | MTD |
| Benjamin Graham | 74D | 65B | ARGX |
| Philip Fisher | 80C | 63C | ARGX |
| Peter Lynch | 71B | 66B | ARGX |
| Joel Greenblatt | 57C | 68B | MTD |
| Charlie Munger | 59D | 74B | MTD |
| Terry Smith | 53D | 70B | MTD |
Side-by-side metrics
| Metric | ARGX | MTD |
|---|---|---|
| Market cap | $49.91B | $22.29B |
| P/E (TTM) | 44.1x | 25.3x |
| EV/EBIT | 44.4x | 21.6x |
| ROIC (TTM) | 11.74% | 36.09% |
| Gross margin | 89.0% | 57.79% |
| Net margin | 33.42% | 21.4% |
| Revenue CAGR 5y | 70.0% | 2.01% |
| EPS CAGR 5y | 42.58% | 6.12% |
| Debt / Equity | 0.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ARGX leads on
- Revenue CAGR 5y70.0%vs 2.01%+97%
- EPS CAGR 5y42.58%vs 6.12%+86%
- Market cap$49.91Bvs $22.29B+55%
- Net margin33.42%vs 21.4%+36%
MTD leads on
- Debt / Equity-vs 0.0x+100%
- ROIC (TTM)36.09%vs 11.74%+67%
- EV/EBIT21.6xvs 44.4x+51%
- P/E (TTM)25.3xvs 44.1x+43%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.